Taiwan Liposome Co Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taiwan Liposome Co Limited with three other
companies in this sector in Taiwan:
Twi Biotechnology Inc
sales of 74.97 million Taiwanese Dollars [US$2.54 million]
of which 70%
was Sales Income),
Lumosa Therapeutics Co Ltd
(35.26 million Taiwanese Dollars [US$1.20 million]
(54.00 million Taiwanese Dollars [US$1.83 million]
of which 61%
During the year ended December of 2017, sales at
Taiwan Liposome Co Limited were 49.64 million Taiwanese Dollars (US$1.68 million).
increase of 19.1%
versus 2016, when the company's sales were 41.67 million Taiwanese Dollars.
Despite this increase, sales are still
below the level achieved in 2015, when Taiwan Liposome Co Limited
reported sales of 59.77 million Taiwanese Dollars.